Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity. - Wikidata - wikimedia - TriplyDB

Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity.

Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity.

http://www.wikidata.org/entity/Q37119899

about

Chemotherapeutic drug susceptibility associated SNPs are enriched in expression quantitative trait loci Pharmacogenomics of chemotherapeutic susceptibility and toxicity Pharmacogenomic discovery using cell-based models Comprehensive survey of SNPs in the Affymetrix exon array using the 1000 Genomes dataset Protein quantitative trait loci identify novel candidates modulating cellular response to chemotherapy Polymorphic variation in TPMT is the principal determinant of TPMT phenotype: A meta-analysis of three genome-wide association studies.Methods of integrating data to uncover genotype-phenotype interactions.An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markers.Impact of the 1000 genomes project on the next wave of pharmacogenomic discovery Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia.Population-specific common SNPs reflect demographic histories and highlight regions of genomic plasticity with functional relevance Genome-wide local ancestry approach identifies genes and variants associated with chemotherapeutic susceptibility in African Americans.Integrating heterogeneous high-throughput data for meta-dimensional pharmacogenomics and disease-related studies Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines.Genetics of human gene expression: mapping DNA variants that influence gene expression.Population differences in the rate of proliferation of international HapMap cell lines.The use of genomic information to optimize cancer chemotherapy A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity.Lymphoblastoid cell lines models of drug response: successes and lessons from this pharmacogenomic model.Chemotherapeutic-induced apoptosis: a phenotype for pharmacogenomics studies.Identification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypes.Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemia.Population differences in microRNA expression and biological implications.The emerging role of microRNAs in drug responses Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation Bioinformatic Resources of microRNA Sequences, Gene Targets, and Genetic Variation.Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy Identification of novel germline polymorphisms governing capecitabine sensitivity.Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients.Genetic and epigenetic variants contributing to clofarabine cytotoxicity.RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patients.Cancer pharmacoethnicity: ethnic differences in susceptibility to the effects of chemotherapy.Use of cell lines in the investigation of pharmacogenetic loci.Genetic factors influencing cytarabine therapy.An integrated genomic approach to the assessment and treatment of acute myeloid leukemia.Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia.Genome-wide transcriptomic variations of human lymphoblastoid cell lines: insights from pairwise gene-expression correlations.SLC29A1 (ENT1) polymorphisms and outcome of complete remission in acute myeloid leukemia.Analysis of innate and acquired resistance to anti-CD20 antibodies in malignant and nonmalignant B cells Genome-wide miRNA expression profiling of human lymphoblastoid cell lines identifies tentative SSRI antidepressant response biomarkers.

P2860

Q24631841-853CA357-028B-4283-9587-4126A11471EA Q27025558-4D5D9C9C-237B-45E9-9257-12123E198BFA Q28392982-B5881E1E-AA36-47F3-A19C-936E1ACD699C Q28472992-B47E9E16-88D3-4439-8617-6CFB19C78739 Q28541831-8A1D05AE-41C7-46A2-9E47-DD4CCD001784 Q30244222-F8E12C20-CBD9-44E0-88D8-4D89BECD2D46 Q30884207-4BDB31A2-02C4-4950-9525-AF78760E0C2E Q33398764-D6921BAF-C514-42D4-9AF4-57C8F5AA81CA Q33708200-A09C2D04-CE35-4EC3-8239-FC163C01A22D Q33799305-966DE0A1-8CB8-47D4-AA50-ACE74F2F4F64 Q33883099-FE585E9E-AA29-4148-94FB-A2E4DB677861 Q33960326-5874339E-21C0-4817-86CA-BD22FDC379EA Q34132233-450D8611-5B13-4199-A233-6471C4F28E05 Q34288272-BA6D465A-51A7-4AB9-98DD-EB87272BFCDA Q34339168-07533E9C-0675-4641-A6B7-9B7F567CA3BD Q34381762-14824736-54C2-4C2A-9FA8-A601C1C32296 Q34791981-D130BB0B-821D-44FA-935E-AE6B677484D0 Q34989475-3E5D4CE1-FB26-4925-BACB-C1F01BAEEE07 Q35068272-C01A0743-EFC5-450D-91D9-9EFE90DDFED6 Q35099987-F0B53A88-6E06-4B3A-A33F-BE1488B687CC Q35114704-335EB040-6FF6-41B7-9368-63B88D369445 Q35265653-CC9E7830-0D71-4465-92B8-F332753E4E5F Q35578546-85C47F34-2720-47EE-BEF9-F69F0C348D27 Q35599477-9E6BBD9B-1708-4082-9A3D-8C988B2FEF46 Q35799841-83F5BAF2-3B63-4D1A-AE56-1B4124B85724 Q35800946-4C4666EB-886F-405F-8303-E143C3220277 Q36117686-0B424B1B-EEC9-463D-B75B-BB377297A84A Q36147462-CDB37B7D-4F39-4360-AE9D-D47305ADE77B Q36873301-A72BE6D6-1B0B-483D-9338-396F3A18DAA4 Q37153800-4CD71EE7-4BA1-498C-9BB4-B77D82735928 Q37387162-D8790182-3CE8-4E08-8D7C-4E10568B479C Q37414536-B7E7EE10-5E4B-462C-A4C6-19480A77C88B Q37436398-3F5D0A1D-8A20-46B5-B65B-648BDC2599AF Q37618228-BB5848EA-3530-4D15-B68D-4D683F1D85A0 Q37855227-CBA8230B-1BC6-4EFB-BBFC-1A0DA736D353 Q38063197-DD3DE944-E821-4180-904D-F407D276B9A5 Q38319500-B21BD518-3BCB-4B09-B3C0-F4EF1217D644 Q38757910-4EFD6A47-BF87-4EA5-A78B-B1C0B8BD32FA Q39157250-6A242C8E-5DC2-43F3-9763-B15D5D4B5435 Q39293823-6DC589B6-B095-4118-B001-30B5D253A5FF

P2860

Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity.

http://www.wikidata.org/entity/Q37119899

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Population-specific genetic va ...... bine arabinoside cytotoxicity.

@en

Population-specific genetic va ...... bine arabinoside cytotoxicity.

@nl

type

label

Population-specific genetic va ...... bine arabinoside cytotoxicity.

@en

Population-specific genetic va ...... bine arabinoside cytotoxicity.

@nl

prefLabel

Population-specific genetic va ...... bine arabinoside cytotoxicity.

@en

Population-specific genetic va ...... bine arabinoside cytotoxicity.

@nl

P1433

Q37119899-C0584014-4FA5-427D-800D-55D6A89507CF

P1476

Q37119899-9A33BFA9-A0C9-4B81-A62E-699902D640AF

P2093

Q37119899-0F6093F5-6C51-4CDF-B274-FFB5250BADFB

Q37119899-0F72BFE6-F894-4052-B2A5-C2AE71C6EC04

Q37119899-49E8B1C3-2B22-4FCD-BBE9-FB90DA43189C

Q37119899-72D703E6-3256-4EF6-97C1-1EE4CBD69377

Q37119899-80007198-FC0C-45D9-AA4B-272339DB7F27

Q37119899-8D3C6233-FD1D-48AF-95FF-D73479176364

Q37119899-E70A1C5A-F530-4B10-92BC-594C58952870

P2860

Q37119899-064A2D1B-B6B3-406C-95BF-E32E92141D68

Q37119899-0A38B125-EA6B-4C83-976B-A1572758F36E

Q37119899-0C97EA00-B8DB-4E7D-9348-F89936C3851D

Q37119899-0CF7371B-A77A-45BF-85CC-B4C9D2C91224

Q37119899-0FC27077-9840-409C-91AD-D8AD60785357

Q37119899-1231CF81-1411-4A76-84C8-6FE66FC6C198

Q37119899-1237A3A6-5E2E-422B-A5AA-EB9169CF9B2C

Q37119899-1C3D6BE8-0960-4EA4-8BB9-D083BA4E06B6

Q37119899-247ED752-F212-4001-B866-FFCB3758E918

Q37119899-251DA85D-B654-4AC9-AAAD-BAFF34E2F061

P304

Q37119899-DAF0AA4F-2755-4030-BF97-1A573C32405C

P31

Q37119899-D97EAD33-3615-4E6F-8969-DA1E31070956

P356

Q37119899-B1A52345-1D12-4DD2-9B10-33EF46386E0D

P407

Q37119899-4117084E-22F6-45CA-AB04-BB2FEB0F4F20

P433

Q37119899-C57B4D2B-38B7-4E47-ABD4-9692C0FB2BEF

P478

Q37119899-BDC70D85-6F8A-44D7-A388-BF78E6063A3F

P50

Q37119899-A3191777-42AB-42EF-A620-53CCA1882206

P577

Q37119899-35187567-DF44-4F20-8C54-133CE671F9E6

P5875

Q37119899-8153FA7F-AF55-486F-A0AB-8E9DEBD3D34E

P698

Q37119899-9B551AAD-3DFC-4B3E-824B-7F9812B4A17E

P921

Q37119899-8CDA701D-5783-4FA0-98A2-DF80D7E12E46

P932

Q37119899-EF533CC5-2324-47B8-8C1B-A5E5FC5EBB11

P356

BLOOD-2008-05-154302

P1433

P1476

Population-specific genetic va ...... abine arabinoside cytotoxicity

@en

P2093

Christine M Hartford

http://www.w3.org/2001/XMLSchema#string

Emily O Kistner

http://www.w3.org/2001/XMLSchema#string

Jatinder K Lamba

http://www.w3.org/2001/XMLSchema#string

M Eileen Dolan

http://www.w3.org/2001/XMLSchema#string

Shannon M Delaney

http://www.w3.org/2001/XMLSchema#string

Shiwei Duan

http://www.w3.org/2001/XMLSchema#string

Shuangli Mi

http://www.w3.org/2001/XMLSchema#string

P2860

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

The multifunctional GIT family of proteins

Mitoferrin is essential for erythroid iron assimilation

Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group

A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity.

Potential mechanisms of resistance to cytarabine in AML patients.

A general test of association for quantitative traits in nuclear families.

Noncardiogenic pulmonary edema: an unusual and serious complication of anticancer therapy.

Cytogenetics in acute leukemia.

P304

2145-2153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2008-05-154302

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

R Stephanie Huang

P577

2008-12-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23699648

http://www.w3.org/2001/XMLSchema#string

P698

19109566

http://www.w3.org/2001/XMLSchema#string

P921

P932

2652364

http://www.w3.org/2001/XMLSchema#string